[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ideaya Biosciences Inc (IDYA)

Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,530,397
  • Shares Outstanding, K 87,861
  • Annual Sales, $ 218,710 K
  • Annual Income, $ -113,700 K
  • EBIT $ -159 M
  • EBITDA $ -165 M
  • 60-Month Beta -0.04
  • Price/Sales 11.61
  • Price/Cash Flow N/A
  • Price/Book 2.48

Options Overview Details

View History
  • Implied Volatility 72.58% (+5.35%)
  • Historical Volatility 49.38%
  • IV Percentile 16%
  • IV Rank 14.12%
  • IV High 198.61% on 03/19/26
  • IV Low 51.87% on 07/21/25
  • Expected Move (DTE 8) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.29
  • Today's Volume 116
  • Volume Avg (30-Day) 2,557
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 39,947
  • Open Int (30-Day) 48,568
  • Expected Range 28.74 to 28.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.18
  • Number of Estimates 4
  • High Estimate $-1.02
  • Low Estimate $-1.28
  • Prior Year $-0.88
  • Growth Rate Est. (year over year) -34.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.83 +3.27%
on 05/06/26
38.10 -24.57%
on 04/13/26
-3.60 (-11.13%)
since 04/06/26
3-Month
27.83 +3.27%
on 05/06/26
38.10 -24.57%
on 04/13/26
-3.43 (-10.66%)
since 02/06/26
52-Week
16.82 +70.87%
on 05/07/25
39.28 -26.83%
on 01/07/26
+10.99 (+61.92%)
since 05/06/25

Most Recent Stories

More News
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. , May 5, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, provided a business update and announced financial...

IDYA : 28.74 (-0.21%)
IDEAYA's Darovasertib Approval Assumption Now Collides With What Revenue Actually Looks Like—Or Doesn't

Barchart Research What to Expect from IDYA Earnings IDYA Generated May 4, 2026 Current Price $28.90 EPS Estimate $$-1.07 Consensus Rating Strong Buy Average Move 4.38% IDEAYA's Darovasertib Approval Assumption...

IDYA : 28.74 (-0.21%)
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. , May 1, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,...

IDYA : 28.74 (-0.21%)
IDEAYA Biosciences Announces Late-Breaking Abstract Oral Presentation at ASCO 2026 to Provide Complete Data from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in 1L HLA*A2-Negative Metastatic Uveal Melanoma

SOUTH SAN FRANCISCO, Calif. , April 21, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced they have been selected for a...

IDYA : 28.74 (-0.21%)
Stocks Settle Higher in Hopes for an Agreement to End the Iran War

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.06%. June E-mini S&P...

IDYA : 28.74 (-0.21%)
AVGO : 425.44 (-0.45%)
INTU : 388.55 (-2.45%)
SNDK : 1,409.98 (+0.26%)
SRE : 93.67 (-0.74%)
$IUXX : 28,599.17 (+2.08%)
ZNM26 : 110-300 (+0.13%)
ESM26 : 7,395.50 (+0.08%)
QCOM : 192.57 (+3.23%)
STX : 786.42 (+2.00%)
BBY : 58.69 (+2.48%)
$DOWI : 49,910.59 (+1.24%)
Stocks Recover as Oracle Leads Software Companies Higher

The S&P 500 Index ($SPX ) (SPY ) today is up +0.09%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. June E-mini S&P futures (ESM26...

ALK : 40.51 (+5.19%)
UAL : 100.04 (+6.80%)
IDYA : 28.74 (-0.21%)
INTU : 388.55 (-2.45%)
SNDK : 1,409.98 (+0.26%)
$IUXX : 28,599.17 (+2.08%)
ZNM26 : 110-300 (+0.13%)
ESM26 : 7,395.50 (+0.08%)
NCLH : 17.75 (+4.78%)
BBY : 58.69 (+2.48%)
$DOWI : 49,910.59 (+1.24%)
SPY : 733.83 (+1.39%)
Stocks Mixed as US Set to Blockade the Strait of Hormuz

The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.21%. Stock indexes are mixed this...

ALK : 40.51 (+5.19%)
MSTR : 186.82 (-0.04%)
UAL : 100.04 (+6.80%)
IDYA : 28.74 (-0.21%)
CVX : 185.16 (-3.88%)
SNDK : 1,409.98 (+0.26%)
GLXY : 31.12 (+2.64%)
$IUXX : 28,599.17 (+2.08%)
COIN : 197.96 (+0.11%)
ZNM26 : 110-300 (+0.13%)
OXY : 55.12 (-7.11%)
FANG : 195.08 (-5.38%)
IDEAYA Biosciences and Servier Announce Positive Topline Results from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA-A*02:01-Negative Metastatic Uveal Melanoma

SOUTH SAN FRANCISCO, Calif. , April 13, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, and Servier, an independent international pharmaceutical...

IDYA : 28.74 (-0.21%)
IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026

SOUTH SAN FRANCISCO, Calif. , April 10, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, today announced plans to issue a joint IDEAYA and Servier...

IDYA : 28.74 (-0.21%)
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer

SOUTH SAN FRANCISCO, Calif. , April 6, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that the first patient has been...

IDYA : 28.74 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences...

See More

Key Turning Points

3rd Resistance Point 30.04
2nd Resistance Point 29.41
1st Resistance Point 29.08
Last Price 28.74
1st Support Level 28.12
2nd Support Level 27.49
3rd Support Level 27.16

See More

52-Week High 39.28
Fibonacci 61.8% 30.70
Last Price 28.74
Fibonacci 50% 28.05
Fibonacci 38.2% 25.40
52-Week Low 16.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.